4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0000899243-19-010033
Options or other derivatives
- Head of Research & Development acquired 375,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Singhal Priya Head of Research & Development | 2019-04-02 | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | D | ||
Loading xslF345X03/doc4.xml…